JPWO2020170211A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020170211A5 JPWO2020170211A5 JP2021549416A JP2021549416A JPWO2020170211A5 JP WO2020170211 A5 JPWO2020170211 A5 JP WO2020170211A5 JP 2021549416 A JP2021549416 A JP 2021549416A JP 2021549416 A JP2021549416 A JP 2021549416A JP WO2020170211 A5 JPWO2020170211 A5 JP WO2020170211A5
- Authority
- JP
- Japan
- Prior art keywords
- daratumumab
- dexamethasone
- seq
- lenalidomide
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025034340A JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962809070P | 2019-02-22 | 2019-02-22 | |
| US62/809,070 | 2019-02-22 | ||
| US201962829814P | 2019-04-05 | 2019-04-05 | |
| US201962829791P | 2019-04-05 | 2019-04-05 | |
| US201962829804P | 2019-04-05 | 2019-04-05 | |
| US62/829,791 | 2019-04-05 | ||
| US62/829,804 | 2019-04-05 | ||
| US62/829,814 | 2019-04-05 | ||
| PCT/IB2020/051484 WO2020170211A1 (en) | 2019-02-22 | 2020-02-21 | Methods of treating newly diagnosed multiple myeloma with a combination of an antibody that specifically binds cd38, lenalidomide and dexamethasone |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034340A Division JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022523372A JP2022523372A (ja) | 2022-04-22 |
| JPWO2020170211A5 true JPWO2020170211A5 (https=) | 2023-06-27 |
| JP2022523372A5 JP2022523372A5 (https=) | 2023-06-27 |
| JP7721445B2 JP7721445B2 (ja) | 2025-08-12 |
Family
ID=72141407
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021549416A Active JP7721445B2 (ja) | 2019-02-22 | 2020-02-21 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
| JP2025034340A Pending JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034340A Pending JP2025102775A (ja) | 2019-02-22 | 2025-03-05 | Ｃｄ３８に特異的に結合する抗体、レナリドミド、及びデキサメタゾンの組み合わせを用いて、新たに診断された多発性骨髄腫を治療する方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20200268847A1 (https=) |
| EP (1) | EP3927376A4 (https=) |
| JP (2) | JP7721445B2 (https=) |
| CN (1) | CN113727729A (https=) |
| CA (1) | CA3131064A1 (https=) |
| WO (1) | WO2020170211A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9603927B2 (en) | 2014-02-28 | 2017-03-28 | Janssen Biotech, Inc. | Combination therapies with anti-CD38 antibodies |
| US9732154B2 (en) | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
| AU2015358615B2 (en) | 2014-12-04 | 2021-08-05 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute myeloid leukemia |
| MX389805B (es) | 2015-05-20 | 2025-03-11 | Janssen Biotech Inc | Anticuerpos anti-cd38 para el tratamiento de amiloidosis de cadena ligera y otras enfermedades malignas hematológicas positivas para cd38. |
| DK3827845T3 (da) | 2015-11-03 | 2022-05-23 | Janssen Biotech Inc | Subkutane formuleringer af anti-cd38-antistoffer og anvendelser deraf |
| JP2019527678A (ja) | 2016-06-28 | 2019-10-03 | ユーエムセー・ユトレヒト・ホールディング・ベー・フェー | ＣＤ３８に特異的に結合する抗体によるＩｇＥ媒介疾患の治療 |
| JP2021502961A (ja) | 2017-10-31 | 2021-02-04 | ヤンセン バイオテツク，インコーポレーテツド | 高リスク多発性骨髄腫の治療方法 |
| WO2023209555A1 (en) | 2022-04-26 | 2023-11-02 | Aragon Pharmaceuticals, Inc. | Approved drug products and methods for treating prostate cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9732154B2 (en) * | 2014-02-28 | 2017-08-15 | Janssen Biotech, Inc. | Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia |
| EP3834889A1 (en) * | 2014-06-16 | 2021-06-16 | Mayo Foundation for Medical Education and Research | Treating myelomas |
| US10617757B2 (en) * | 2014-08-08 | 2020-04-14 | The Regents Of The University Of California | Methods for treating multiple myeloma |
| US20170044265A1 (en) * | 2015-06-24 | 2017-02-16 | Janssen Biotech, Inc. | Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38 |
-
2020
- 2020-02-21 CN CN202080015963.2A patent/CN113727729A/zh active Pending
- 2020-02-21 WO PCT/IB2020/051484 patent/WO2020170211A1/en not_active Ceased
- 2020-02-21 JP JP2021549416A patent/JP7721445B2/ja active Active
- 2020-02-21 EP EP20759735.2A patent/EP3927376A4/en active Pending
- 2020-02-21 US US16/797,301 patent/US20200268847A1/en active Pending
- 2020-02-21 CA CA3131064A patent/CA3131064A1/en active Pending
-
2025
- 2025-03-05 JP JP2025034340A patent/JP2025102775A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7575526B2 (ja) | Ｉｌ－４ｒ阻害剤の投与によるアレルギー処置方法およびアレルゲン特異的免疫療法の向上方法 | |
| JP7164530B2 (ja) | Ｉｌ－４ｒ阻害剤を投与することによって重度のアトピー性皮膚炎を処置するための方法 | |
| CN106456751B (zh) | 治疗指甲和头皮银屑病的方法 | |
| EP4212160A1 (en) | Use of chiauranib in combination with immune checkpoint inhibitor in antitumor therapy | |
| JP2025102775A5 (https=) | ||
| JP2024028865A (ja) | 抗ｃｄ１９抗体とベネトクラクスとの組み合わせ治療のための治療パラダイム | |
| JPWO2020170211A5 (https=) | ||
| CN109641965A (zh) | 使用奥法木单抗治疗多发性硬化的方案和方法 | |
| JPWO2020232173A5 (https=) | ||
| EP4410836A1 (en) | Anti-cd47 antibody for combined treatment of blood tumor | |
| CA3215919A1 (en) | Treatment for systemic lupus erythematosus using anti-baffr antibodies | |
| HK40022146A (en) | Methods for enhancing allergen-specific immunotherapy by administering an il-4r inhibitor | |
| TW202608479A (zh) | 治療具有類風濕性關節炎的個體中疼痛之組成物及方法 | |
| KR20260056325A (ko) | Il-4r 억제제를 투여하여 아토피성 피부염을 치료하는 방법 | |
| KR20210010518A (ko) | Il-4r 억제제를 투여하여 아토피성 피부염을 치료하는 방법 | |
| JPWO2020250033A5 (https=) | ||
| WO2012121958A2 (en) | Combination | |
| HK1216898B (en) | Methods for enhancing allergen-specific immunotherapy by administering an il-4r inhibitor |